EXOSOMM ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Biotech-FoodTech company developing medical food formulas from milk exosomes for IBD, focused on immune regulation and gut health.

Health Tech & Life Sciences
Active
Seed Safed, Israel Founded 2021
Last updated 2026-07-26
Total raised
$4.4M
Last: Grant 2025-03
Stage
Seed
Founded
2021
Headcount
1
HQ
Safed, Israel
Sector
Health Tech & Life Sciences

About

EXOSOMM is an Israeli BioTech-FoodTech startup that has developed a proprietary, patent-protected, chemical-free process to isolate bioactive milk exosomes from cow milk whey at an industrial scale. These nano-sized vesicles carry microRNAs, proteins, and lipids that support immune regulation, gut health, and anti-inflammatory responses. The company's initial product is a food formula targeting Inflammatory Bowel Disease (IBD) and plans to expand into nutraceuticals, functional nutrition, and skincare products. EXOSOMM's technology transforms dairy side-stream waste into high-value therapeutic solutions, with an annual production capacity of 200 metric tons and a shelf life exceeding one year.

Funding history · 6 rounds · $4.4M total

2025-02
Grant $1.5M
2024-12
Seed $1.7M
★ SOSV★ AgFunder★ Tnuva Ventures★ Siddhi Capital★ Mor Research Applications
2024-02
Grant $80K
2023-02
Grant $420K
2021-11
Pre-Seed Undisclosed
★ G.O Innovation
2021-11
Grant $700K

Headcount over time

From 1 (2022-03) to 7 (2025-12) · +6 (+600%) · 10 points · source: Finder history + radar grounding
90 2022-03 2025-12

Q&A

What is EXOSOMM's primary focus?
EXOSOMM is a Biotech-FoodTech company developing medical food formulas from milk exosomes for Inflammatory Bowel Disease (IBD), with a focus on immune regulation and gut health.
When was EXOSOMM founded?
EXOSOMM was founded in December 2021.
What was EXOSOMM's most recent funding event?
In March 2025, EXOSOMM received a Grant of $1,500,000 from the Israel Innovation Authority.
Which investors participated in EXOSOMM's Seed round in January 2025?
In January 2025, EXOSOMM raised $2,000,000 in a Seed round with participation from Tnuva Ventures.
What is EXOSOMM's core technology?
EXOSOMM has developed a proprietary, patent-protected, chemical-free process to isolate bioactive milk exosomes from cow milk whey at an industrial scale, which carry microRNAs, proteins, and lipids for immune regulation, gut health, and anti-inflammatory responses.
What is the initial product EXOSOMM is targeting?
EXOSOMM's initial product is a food formula targeting Inflammatory Bowel Disease (IBD).
What is EXOSOMM's total funding raised to date?
EXOSOMM has raised a total of $4,520,000 to date.

Team · 4

Netta Granot
Founder · CEO & Co-founder
Regina Golan-Gerstl
Founder · CTO & Co-founder
Prof. Shimon Reif
Founder · CMO & Co-founder
Yaffa Elbaum Shiff
Founder · COO & Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Agriculture & Food TechnologiesFood TechNovel Food & IngredientsHealth Tech & Life SciencesPharma & Medical Biotechnology
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyCosmeticsHealthcarePatientsProvidersMedical Devices IndustryMedical ProductsFood Retail & ConsumptionWholesaleAgriculture & FoodProcessed FoodsBeveragesIngredientsConsumers
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

novel-ingredientsmedical-productsanti-inflammatorybiotechnologyprecision-medicinehealthcaredermatologyfood-additivesbiomedfood-ingredientsinflammatory-diseasescosmeticsnatural-active-ingredientsfood-industrycosmetic-companiesdairy-farmsfoodtechwellnesspopulation-health-managementnutrition
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteexosomm.com/
LinkedInlinkedin.com/company/77060409
Facebookfacebook.com/Exosomm

Identifiers & details

Former namesEXOSOMM
Founded2021-12
Employees (exact)1

Radar intelligence

Web history (Wayback)

Domainexosomm.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516506813
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-12-07
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens1
Registry events5 — people (2), shares_capital (2), charge (1)
Registered addressהנמל 28 חיפה

Recent registry events

DateEvent
2025-07-30עדכון דירקטורים-הוספת דירקטור
2025-07-30עדכון דירקטורים-הסרת דירקטור
2026-03-30שינוי בהרכב הון - מניות-הפחתת הון מוקצה
2026-04-27רישום שעבוד
2026-03-22הקצאת מניות